Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Worse Disease-Free Survival in Never-Smokers with ALK+ Lung Adenocarcinoma

Published:2012-01 Issue:1 Volume:7 Page:90-97
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yang Ping,Kulig Kimary,Boland Jennifer M.,Erickson-Johnson Michele R.,Oliveira Andre M.,Wampfler Jason,Jatoi Aminah,Deschamps Claude,Marks Randolph,Fortner Connie,Stoddard Shawn,Nichols Francis,Molina Julian,Aubry Marie-Christine,Tang Hui,Yi Eunhee S.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Identification of the transforming EML4-ALK fusion gene in on-small-cell lung cancer;Soda;Nature,2007

2. Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors;Koh;J Thorac Oncol,2011

3. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

4. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res,2009

5. A novel KIF5B-ALK variant in nonsmall cell lung cancer;Wong;Cancer,2011

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?;Expert Opinion on Therapeutic Targets;2024-08-19

2. Lung adenocarcinoma patients with ROS1-rearranged tumors by sex and smoking intensity;Heliyon;2024-04

3. Environment-Sensitive Fluorescent Probe Enables Assessment of Anaplastic Lymphoma Kinase Activity in Nonsmall Cell Lung Cancer;Analytical Chemistry;2024-02-12

4. Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center;Translational Lung Cancer Research;2024-01

5. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges;Frontiers in Oncology;2023-12-08